Anmeldung erfolgt in Kürze...
Details werden geladen...
Delhi HC seeks response on Natco's patent challenge plea - The Economic Times
The Delhi High Court is reviewing Natco Pharma's challenge to a breast cancer drug patent. Natco alleges Novartis and Astex secured two patents for the same invention. This action, Natco claims, unlawfully extends patent protection for the Ribociclib molecule. The court will first determine the petition's maintainability after legal arguments. The case has been scheduled for further hearing on September 16.
Ähnliche Seiten
Natco challenges Novartis’s second patent for cancer drug ribociclib in Delhi High Court | Company Business News
https://www.livemint.com/companies/news/natco-challenges-novartis-second-patent-for-cancer-drug-ribociclib-in-delhi-high-court-11785925706550.html
Delhi HC seeks reply from ‘Kala Hiran’ makers on Salman Khan plea - The Economic Times
https://economictimes.indiatimes.com/news/india/delhi-hc-seeks-reply-from-kala-hiran-makers-on-salman-khan-plea/articleshow/131684985.cms
2020 Delhi riots case: HC seeks police response on Umar Khalid’s bail plea
https://scroll.in/latest/1094684/2020-delhi-riots-case-hc-seeks-police-response-on-umar-khalids-bail-pleaHC seeks Delhi govt's stand on private schools' plea over constitution of fee regulation committee - The Economic Times
https://economictimes.indiatimes.com/news/india/hc-seeks-delhi-govts-stand-on-private-schools-plea-over-constitution-of-fee-regulation-committee/articleshow/132307515.cmsDelhi HC seeks police response on Sharjeel Imam's bail plea in 2020 riots conspiracy case - The Economic Times
https://economictimes.indiatimes.com/news/politics-and-nation/delhi-hc-seeks-police-response-on-sharjeel-imams-bail-plea-in-2020-riots-conspiracy-case/articleshow/132453665.cms